Comparative Efficacy and Safety of Deferoxamine, Deferiprone and Deferasirox on Severe Thalassemia: A Meta-Analysis of 16 Randomized Controlled Trials

Open Access

Peer-reviewed

Research Article

Sujian Xia,

Affiliation Division of Medical Statistics, School of Medicine, University of Jinan, Guangzhou City, Guangdong, China
⨯
Weidong Zhang,

Affiliation Novartis Pharmaceuticals Oncology, Beijing, China
⨯
Liting Huang ,

* Email: ting.hwang30@gmail.com

Affiliation Zhuhai People’s Hospital, Zhuhai City, Guangdong, China
⨯
Hong Jiang

Affiliation Division of Medical Statistics, School of Medicine, University of Jinan, Guangzhou City, Guangdong, China
⨯

x

Viewed

Powered by Altmetric

Questions or concerns about usage data? Please let us know.

Print

Low income countries
Is the Subject Area "Low income countries" applicable to this article?

Thanks for your feedback.
Metaanalysis
Is the Subject Area "Metaanalysis" applicable to this article?

Thanks for your feedback.
Medical risk factors
Is the Subject Area "Medical risk factors" applicable to this article?

Thanks for your feedback.
Magnetic resonance imaging
Is the Subject Area "Magnetic resonance imaging" applicable to this article?

Thanks for your feedback.
Adverse events
Is the Subject Area "Adverse events" applicable to this article?

Thanks for your feedback.
Neutropenia
Is the Subject Area "Neutropenia" applicable to this article?

Thanks for your feedback.
Randomized controlled trials
Is the Subject Area "Randomized controlled trials" applicable to this article?

Thanks for your feedback.
Thalassemia
Is the Subject Area "Thalassemia" applicable to this article?

Thanks for your feedback.